You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: January 10, 2025

Details for Patent: 5,075,445


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 5,075,445
Title: Guanine derivatives
Abstract:A compound of formula (I) ##STR1## or a salt or acyl derivative thereof, in which X represents chlorine, C.sub.1-6 alkoxy, phenoxy, phenyl C.sub.1-6 alkoxy, NH.sub.2, --OH or --SH, is useful in treating viral infections.
Inventor(s): Jarvest; Richard L. (Surbiton, GB), Harnden; Michael R. (Horsham, GB)
Assignee: Beecham Group p.l.c. (Middlesex, GB)
Application Number:07/085,216
Patent Claim Types:
see list of patent claims
Compound;
Patent landscape, scope, and claims:

Detailed Analysis of the Scope and Claims of United States Patent 5,075,445

Introduction

United States Patent 5,075,445, titled "Guanine derivatives," was issued to the inventors for their work on compounds with antiviral activity, particularly against herpes viruses. This patent is a significant contribution to the field of pharmaceuticals and antiviral treatments.

Patent Overview

Publication Number and Authority The patent, numbered US5075445A, was granted by the United States Patent and Trademark Office (USPTO) and is categorized under the authority of the United States[4].

Invention Description The patent describes a series of guanine derivatives that exhibit antiviral properties. These compounds are designed to treat infections caused by herpes viruses. The invention includes the chemical compounds themselves, processes for their preparation, and pharmaceutical compositions containing these compounds[4][5].

Scope of the Patent

Chemical Compounds

The patent focuses on guanine derivatives, which are modified versions of the guanine base found in DNA and RNA. These derivatives include various substitutions and modifications that enhance their antiviral efficacy. For example, the patent mentions compounds like Penciclovir, which is a guanine derivative with significant antiviral activity against herpes viruses[4].

Antiviral Activity

The compounds described in the patent have been tested for their ability to inhibit the replication of herpes viruses. The antiviral effects are attributed to the ability of these compounds to interfere with the viral DNA synthesis process, thereby preventing the virus from replicating[4].

Pharmaceutical Compositions

The patent also covers pharmaceutical compositions that contain these guanine derivatives. These compositions can be formulated in various ways, such as tablets, capsules, or solutions, to facilitate administration and treatment of viral infections[5].

Claims of the Patent

The claims of the patent are crucial as they define the scope of protection granted to the inventors.

Independent Claims

The patent includes several independent claims that describe the core inventions:

  • Claim 1: This claim describes the general structure of the guanine derivatives, including specific substitutions and modifications that confer antiviral activity[4].
  • Claim 2: This claim covers the processes for preparing these guanine derivatives, including the chemical reactions and conditions necessary for their synthesis[4].

Dependent Claims

Dependent claims further specify the scope by detailing particular aspects of the invention, such as:

  • Claim 3: This claim specifies the pharmaceutical compositions containing the guanine derivatives and their methods of administration[4].
  • Claim 4: This claim describes the therapeutic uses of these compounds, particularly in treating viral infections caused by herpes viruses[4].

Patent Landscape

Prior Art and Citations

The patent cites several prior art references that relate to antiviral compounds and their synthesis. These citations indicate the state of the art at the time of the invention and help to distinguish the novelty of the claimed compounds and processes[4].

Related Patents and Applications

The patent is part of a broader landscape of antiviral research and development. Other patents and applications in this field may relate to similar compounds or different approaches to treating viral infections. For instance, the Common Citation Document (CCD) application by the USPTO consolidates prior art cited by multiple offices for the same invention, which can help in understanding the global patent landscape for similar inventions[1].

International Patent Family

To understand the global reach of this patent, one would need to look at the patent family, which includes related applications filed in other countries. Tools like the Global Dossier provided by the USPTO can help in identifying the patent family and accessing file histories of related applications from participating IP Offices[1].

Legal Status

The patent has expired, as indicated by its legal status. This means that the exclusive rights granted to the inventors have lapsed, and the technology described in the patent is now in the public domain[4].

Key Takeaways

  • Antiviral Compounds: The patent describes guanine derivatives with significant antiviral activity against herpes viruses.
  • Pharmaceutical Compositions: The invention includes pharmaceutical compositions containing these compounds.
  • Expired Patent: The patent has expired, making the technology publicly available.
  • Global Landscape: Understanding the patent family and related international applications is crucial for a comprehensive view of the patent landscape.

FAQs

Q: What is the main focus of United States Patent 5,075,445? A: The main focus is on guanine derivatives with antiviral activity, particularly against herpes viruses.

Q: What are the key claims of the patent? A: The key claims include the structure of the guanine derivatives, processes for their preparation, and pharmaceutical compositions containing these compounds.

Q: Is the patent still in force? A: No, the patent has expired, and the technology is now in the public domain.

Q: How can one find related international patents? A: Tools like the Global Dossier provided by the USPTO can help in identifying the patent family and accessing file histories of related applications.

Q: What is the significance of the Common Citation Document (CCD) in this context? A: The CCD consolidates prior art cited by multiple offices for the same invention, helping to understand the global patent landscape for similar inventions.

Sources

  1. USPTO - Search for patents: https://www.uspto.gov/patents/search
  2. USPTO - NOTICE OF FINAL DETERMINATION: https://www.uspto.gov/web/offices/com/sol/foia/tac/pte/5075445.pdf
  3. USPTO - Patent Claims Research Dataset: https://www.uspto.gov/ip-policy/economic-research/research-datasets/patent-claims-research-dataset
  4. Google Patents - US5075445A: https://patents.google.com/patent/US5075445A/en
  5. Justia Patents - US Patent for Guanine derivatives: https://patents.justia.com/patent/5075445

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 5,075,445

ApplicantTradenameGeneric NameDosageNDAApproval DateTETypeRLDRSPatent No.Patent ExpirationProductSubstanceDelist Req.Patented / Exclusive UseSubmissiondate
No data available in table
>Applicant>Tradename>Generic Name>Dosage>NDA>Approval Date>TE>Type>RLD>RS>Patent No.>Patent Expiration>Product>Substance>Delist Req.>Patented / Exclusive Use>Submissiondate
Showing 0 to 0 of 0 entries

Foreign Priority and PCT Information for Patent: 5,075,445

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
United Kingdom8322199Aug 18, 1983
United Kingdom8325271Sep 21, 1983
United Kingdom8408322Mar 30, 1984

International Family Members for US Patent 5,075,445

CountryPatent NumberEstimated ExpirationSupplementary Protection CertificateSPC CountrySPC Expiration
European Patent Office 0141927 ⤷  Subscribe SPC/GB96/014 United Kingdom ⤷  Subscribe
European Patent Office 0141927 ⤷  Subscribe 97C0033 Belgium ⤷  Subscribe
European Patent Office 0182024 ⤷  Subscribe SPC/GB94/002 United Kingdom ⤷  Subscribe
>Country>Patent Number>Estimated Expiration>Supplementary Protection Certificate>SPC Country>SPC Expiration
Showing 1 to 3 of 3 entries

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.